Business of the House

Greg Mulholland Excerpts

Thursday 3rd March 2016 Commons Chamber

[Chris Grayling]

Well, Mr Speaker, we were all waiting—and we were not disappointed. I gather that my hon. Friend has now got his petition past 20,000 signatures, so we are on the way to debating it in the House, for which I commend him. This nation’s hedgehog population has every reason to be grateful to him. On a more serious note, the solution to the problem is very much at the heart of this Government’s strategy, with the huge expansion in the number of apprenticeships. In my view, these provide the best way of ensuring that we have the breadth of engineering skills that we need.

[Greg Mulholland (Leeds North West) (LD)]

A year ago today, the Tuberous Sclerosis Association started its “fight4treatment” campaign because sufferers of this pernicious disease are currently not able to access everolimus, the life-saving drug that they so desperately need. A year on, may we finally have a statement from a Health Minister about when the sufferers from this ultra-rare condition can finally get access to the treatment that can save their lives?

[Chris Grayling]

This is of course a matter that would normally go through the procedures of the National Institute for Health and Care Excellence, which decides which drugs it is right for the NHS to offer. I will, however, ask the Department of Health to respond to the hon. Gentleman on the issue he has raised.